NWAM LLC’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.25M | Sell |
51,769
-2,118
| -4% | -$55.4K | 0.06% | 291 |
|
|
2026
Q1 | $1.51M | Buy |
53,887
+10,531
| +24% | +$280K | 0.09% | 217 |
|
|
2025
Q4 | $1.12M | Sell |
43,356
-274
| -0.6% | -$6.91K | 0.06% | 259 |
|
|
2025
Q3 | $1.08M | Sell |
43,630
-4,160
| -9% | -$103K | 0.06% | 266 |
|
|
2025
Q2 | $1.12M | Sell |
47,790
-117
| -0.2% | -$2.73K | 0.07% | 251 |
|
|
2025
Q1 | $1.21M | Sell |
47,907
-2,508
| -5% | -$65.6K | 0.1% | 180 |
|
|
2024
Q4 | $1.34M | Sell |
50,415
-3,921
| -7% | -$106K | 0.08% | 221 |
|
|
2024
Q3 | $1.57M | Sell |
54,336
-576
| -1% | -$16.8K | 0.1% | 203 |
|
|
2024
Q2 | $1.54M | Buy |
54,912
+1,703
| +3% | +$46.9K | 0.45% | 39 |
|
|
2024
Q1 | $1.48M | Sell |
53,209
-9,496
| -15% | -$264K | 0.12% | 168 |
|
|
2023
Q4 | $1.81M | Sell |
62,705
-1,831
| -3% | -$55.4K | 0.15% | 139 |
|
|
2023
Q3 | $2.14M | Sell |
64,536
-8,282
| -11% | -$293K | 0.22% | 105 |
|
|
2023
Q2 | $2.67M | Buy |
72,818
+2,908
| +4% | +$113K | 0.22% | 105 |
|
|
2023
Q1 | $2.85M | Sell |
69,910
-3,676
| -5% | -$159K | 0.29% | 89 |
|
|
2022
Q4 | $3.77M | Sell |
73,586
-2,258
| -3% | -$108K | 0.33% | 86 |
|
|
2022
Q3 | $3.32M | Sell |
75,844
-1,341
| -2% | -$65.2K | 0.32% | 78 |
|
|
2022
Q2 | $3.99M | Buy |
77,185
+5,622
| +8% | +$286K | 0.37% | 61 |
|
|
2022
Q1 | $3.71M | Buy |
71,563
+4,340
| +6% | +$225K | 0.28% | 86 |
|
|
2021
Q4 | $3.97M | Buy |
67,223
+729
| +1% | +$36.1K | 0.31% | 78 |
|
|
2021
Q3 | $2.86M | Buy |
66,494
+933
| +1% | +$41.3K | 0.26% | 93 |
|
|
2021
Q2 | $2.57M | Sell |
65,561
-3,199
| -5% | -$124K | 0.24% | 102 |
|
|
2021
Q1 | $2.49M | Sell |
68,760
-17,728
| -20% | -$629K | 0.25% | 100 |
|
|
2020
Q4 | $3.18M | Sell |
86,488
-3,753
| -4% | -$138K | 0.36% | 71 |
|
|
2020
Q3 | $3.14M | Sell |
90,241
-6,173
| -6% | -$216K | 0.52% | 58 |
|
|
2020
Q2 | $2.99M | Buy |
+96,414
| New | +$3.28M | 0.42% | 57 |
|
|
2019
Q4 | $2.71M | Buy |
72,798
+8,864
| +14% | +$316K | 0.47% | 49 |
|
|
2019
Q3 | $2.18M | Sell |
63,934
-1,664
| -3% | -$60.5K | 0.41% | 53 |
|
|
2019
Q2 | $2.7M | Buy |
65,598
+6,923
| +12% | +$275K | 0.54% | 38 |
|
|
2019
Q1 | $2.36M | Sell |
58,675
-550
| -0.9% | -$22K | 0.51% | 42 |
|
|
2018
Q4 | $2.45M | Buy |
59,225
+1,452
| +3% | +$60.3K | 0.63% | 36 |
|
|
2018
Q3 | $2.42M | Sell |
57,773
-2,812
| -5% | -$108K | 0.54% | 38 |
|
|
2018
Q2 | $2.08M | Buy |
60,585
+711
| +1% | +$24.3K | 0.49% | 48 |
|
|
2018
Q1 | $2.02M | Sell |
59,874
-687
| -1% | -$23.6K | 0.51% | 47 |
|
|
2017
Q4 | $2.08M | Buy |
60,561
+3,109
| +5% | +$106K | 0.53% | 48 |
|
|
2017
Q3 | $1.95M | Sell |
57,452
-551
| -0.9% | -$17.7K | 0.51% | 50 |
|
|
2017
Q2 | $1.85M | Buy |
58,003
+1,313
| +2% | +$41.4K | 0.32% | 50 |
|
|
2017
Q1 | $1.84M | Buy |
56,690
+2,844
| +5% | +$89.7K | 0.56% | 41 |
|
|
2016
Q4 | $1.66M | Sell |
53,846
-802
| -1% | -$24.5K | 0.55% | 44 |
|
|
2016
Q3 | $1.76M | Buy |
54,648
+1,381
| +3% | +$46.2K | 0.13% | 43 |
|
|
2016
Q2 | $1.78M | Sell |
53,267
-1,234
| -2% | -$39.4K | 0.7% | 34 |
|
|
2016
Q1 | $1.53M | Buy |
54,501
+17,876
| +49% | +$511K | 0.61% | 40 |
|
|
2015
Q4 | $1.12M | Sell |
36,625
-265
| -0.7% | -$8.34K | 0.46% | 56 |
|
|
2015
Q3 | $1.1M | Sell |
36,890
-3,162
| -8% | -$101K | 0.91% | 27 |
|
|
2015
Q2 | $1.26M | Buy |
40,052
+7,387
| +23% | +$241K | 0.53% | 43 |
|
|
2015
Q1 | $1.08M | Buy |
32,665
+1,026
| +3% | +$32.6K | 0.46% | 52 |
|
|
2014
Q4 | $935K | Sell |
31,639
-37,201
| -54% | -$1.07M | 0.41% | 61 |
|
|
2014
Q3 | $1.93M | Sell |
68,840
-20,231
| -23% | -$568K | 0.69% | 35 |
|
|
2014
Q2 | $2.51M | Buy |
89,071
+8,911
| +11% | +$254K | 0.78% | 34 |
|
|
2014
Q1 | $2.44M | Buy |
80,160
+35,009
| +78% | +$1.04M | 0.84% | 35 |
|
|
2013
Q4 | $1.31M | Sell |
45,151
-26,376
| -37% | -$768K | 0.7% | 53 |
|
|
2013
Q3 | $1.95M | Sell |
71,527
-2,075
| -3% | -$56.5K | 0.95% | 36 |
|
|
2013
Q2 | $1.96M | Buy |
+73,602
| New | +$2.03M | 0.99% | 36 |
|
Other funds holding PFE
NWAM LLC's PFE Position: Q2 2026 in Review
NWAM LLC reduced its Pfizer (PFE) stake by 3.9% in Q2 2026, selling an estimated $55.4K and leaving 51,769 shares worth $1.25M. The position accounts for 0.06% of the portfolio, ranked #291.
NWAM LLC first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.99M in Q2 2022. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- NWAM LLC held 51,769 shares of Pfizer worth $1.25M as of Q2 2026.
- NWAM LLC sold 2,118 Pfizer shares in Q2 2026, an estimated $55.4K.
- Pfizer made up 0.06% of NWAM LLC's portfolio in Q2 2026, its #291 holding.
- NWAM LLC first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- NWAM LLC's Pfizer position peaked at $3.99M in Q2 2022.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on NWAM LLC's 13F filing for Q2 2026, filed 23 Jul 2026.